BLGO · XBRL financial data

Biolargo financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (BLGO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue	—	—	—	12,230	—	—
Cost of goods and services sold	1,204	1,428	3,027	6,076	9,926	4,359
Gross profit	1,228	1,103	2,857	6,154	7,853	3,406
Research and development	1,338	1,367	1,319	2,282	2,882	2,593
Selling, general and administrative	7,473	6,172	6,731	8,058	9,302	11,768
Total operating expenses	8,811	7,539	8,247	10,734	12,184	18,261
Operating income (loss)	(7,583)	(6,436)	(5,390)	(4,580)	(4,331)	(14,855)
Interest income	—	—	—	—	33	200
Interest expense	1,923	234	53	91	71	540
Other income (expense)	(2,117)	(458)	258	(68)	—	—
Income tax expense (benefit)	—	—	—	0	0	—
Earnings per share, basic USD per share	—	(0.03)	(0.02)	(0.02)	(0.01)	(0.04)
Weighted average shares, basic thousands of shares	195,994	247,204	268,302	285,957	298,122	306,955

Fiscal years (BLGO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	716	962	1,851	3,539	3,548	3,883
Accounts receivable	484	513	1,064	2,612	3,168	615
Inventory	277	241	120	153	330	310
Prepaid and other current assets	28	85	118	58	91	306
Total current assets	1,505	1,801	3,153	6,362	7,137	5,114
Property and equipment, net	60	61	287	662	1,742	1,643
Right-of-use asset	341	453	867	1,092	992	1,028
Total assets	4,942	3,023	4,858	8,205	10,513	8,311
Accounts payable	315	350	717	1,212	826	1,012
Current portion of long-term debt	—	314	100	—	552	—
Total current liabilities	3,544	1,374	1,576	2,710	2,648	5,063
Long-term debt	507	180	237	289	—	—
Lease liability, non-current	226	349	773	1,004	922	864
Total liabilities	5,177	2,090	2,847	4,003	4,457	6,785
Accumulated deficit	(132,041)	(139,121)	(143,594)	(147,098)	(149,500)	(161,280)
Total stockholders' equity	3,858	4,653	4,878	6,844	8,851	4,042
Total liabilities and equity	4,942	3,023	4,858	8,205	10,513	8,311
Common shares outstanding (cover page) thousands of shares	238,776	262,723	283,192	295,553	301,303	319,751

Fiscal years (BLGO's year ends in late December)

In thousands of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Stock-based compensation	2,459	1,872	2,071	2,124	2,063	2,965
Net cash from operating activities	(4,154)	(3,937)	(2,762)	(2,365)	(3,206)	(8,297)
Net cash from investing activities	(123)	(34)	(271)	(478)	(1,317)	435
Proceeds from issuing common stock	2,783	4,882	3,617	2,153	594	2,027
Net cash from financing activities	4,340	4,231	3,956	4,659	4,438	8,221
Net change in cash	61	246	889	1,688	9	335

SIC 2800 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 2800 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Biolargo	2,188	not reported	(3,056)*	328.7M	0.7 quarters	Q2 FY26 10-QJun 30, 2026
Liquidmetal Technologies	8,266	not reported	(193)*	917.3M	76.6 quarters	Q2 FY26 10-QJun 30, 2026
Loop Industries	836	117	(1,165)*	48.8M	0.7 quarters	Q2 FY27 10-QAug 31, 2026
CitroTech	2,519	281	(1,783)*	22.6M	1.4 quarters	Q2 FY26 10-Q/AJun 30, 2026
Ascent Industries	28,069	25,667	(2,296)*	9.0M	12.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.